Search company, investor...

Predict your next investment

Alive Israel HealthTech Fund company logo
Venture Capital
alivevc.com

Investments

14

Funds

1

About Alive Israel HealthTech Fund

Alive Israel HealthTech Fund operates as a mid-to-late stage HealthTech fund. The company's main service is to provide financial support and acceleration to portfolio companies in their clinical and commercial expansion, leveraging an exclusive ecosystem of strategic partnerships with hospital chains, HMOs, and financial institutions. The company primarily sells to the healthcare technology industry. It was founded in 2020 and is based in Tel Aviv, Israel.

Headquarters Location

10 Habarzel street

Tel Aviv,

Israel

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest Alive Israel HealthTech Fund News

Thesis: $13.5 Million Raised For Customized Approaches To Cognitive Performance Products

May 16, 2023

Thesis – a company that offers a customized approach to cognitive performance products based on your unique brain chemistry – announced that it has raised over $13.5 million in funding. The company had recently closed on a Series A round totaling $8.4 million with investors that included Unilever Ventures, Redo Ventures, Alive VC, Break Trail, NBA superstar Kevin Love and model Kate Bock. Previously the company raised $5.1 million in an undisclosed seed round that included Unilever Ventures, MBX, Trust Ventures and Redo Ventures. The company recognizes that nootropics are not a one-size-fits-all wellness category. And through the highest quality ingredients and a customized approach, the brand helps people effectively boost their cognition & productivity. The new funding round will support Thesis as it makes key executive hires, expands out its product selection and undergoes clinical trials. And Thesis’ products are formulated with clinically studied active ingredients with the highest possible bioavailability and adhere to the FDA Current Good Manufacturing Processes (cGMP). KEY QUOTES: “Nootropics have helped me a great deal, as someone who originally struggled in school and who eventually went on to graduate from some of the world’s most prestigious universities. I spent a significant amount of time learning about these compounds and finding the blend that worked for me. It shouldn’t be so hard, I created Thesis products for people who feel that they might not be living up to their full potential and want a real solution to close the gap.” — Dan Freed, founder and CEO of Thesis “In today’s ‘always on’ world, consumers are increasingly looking for solutions to optimize their mental acuity and the demand for products that allow you to perform at your best has never been greater. With Thesis’s customized offering, education-focused and digital-first model rooted in a highly compelling founder story, we have been impressed by Dan’s vision and the exacting standards that he is setting for the brand. We are excited to support him on the next chapter of the business’s growth.” — Rachel Harris, Partner at Unilever Ventures “I am excited to be part of Dan’s vision of customized health and wellness solutions. Thesis is defining a new wellness category and reshaping how people approach brain care.” — Michael Lynton, Thesis Board Director Trending on Pulse 2.0

Alive Israel HealthTech Fund Investments

14 Investments

Alive Israel HealthTech Fund has made 14 investments. Their latest investment was in Vessi Medical as part of their Series A on February 14, 2024.

CBI Logo

Alive Israel HealthTech Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/14/2024

Series A

Vessi Medical

$16.5M

Yes

Agriline, The Trendlines Group, and Undisclosed Investors

2

8/29/2023

Seed VC

Nevia Bio

$3.1M

Yes

1

7/6/2023

Series A - II

Append Medical

$4.35M

Yes

Shoni Health Ventures, and Undisclosed Investors

1

5/3/2023

Series D

Subscribe to see more

$99M

Subscribe to see more

10

5/2/2023

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/14/2024

8/29/2023

7/6/2023

5/3/2023

5/2/2023

Round

Series A

Seed VC

Series A - II

Series D

Series A

Company

Vessi Medical

Nevia Bio

Append Medical

Subscribe to see more

Subscribe to see more

Amount

$16.5M

$3.1M

$4.35M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Agriline, The Trendlines Group, and Undisclosed Investors

Shoni Health Ventures, and Undisclosed Investors

Sources

2

1

1

10

10

Alive Israel HealthTech Fund Fund History

1 Fund History

Alive Israel HealthTech Fund has 1 fund, including ALIVE HealthTech Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

8/10/2020

ALIVE HealthTech Fund

$150M

1

Closing Date

8/10/2020

Fund

ALIVE HealthTech Fund

Fund Type

Status

Amount

$150M

Sources

1

Alive Israel HealthTech Fund Team

3 Team Members

Alive Israel HealthTech Fund has 3 team members, including current Founder, Managing General Partner, Michel Habib.

Name

Work History

Title

Status

Michel Habib

Hadasit Bio Holdings, Agate Medical Investments, Elron Ventures, ING Financial Markets, and GeorgiaGov

Founder, Managing General Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Michel Habib

Subscribe to see more

Subscribe to see more

Work History

Hadasit Bio Holdings, Agate Medical Investments, Elron Ventures, ING Financial Markets, and GeorgiaGov

Title

Founder, Managing General Partner

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.